Children and their families are at the center of all we do.
PLEASE NOTE: Because the health and safety of our patients, families, visitors and staff is of utmost importance to us and to prevent the spread of the virus causing COVID19 illness, new visitation restrictions are effective beginning March 11, 2020.
Learn about the new policy
Ann & Robert H. Lurie Children's Hospital of Chicago
225 E. Chicago Ave., Chicago, Illinois 60611
Research at Lurie Children’s is conducted through Stanley Manne Children's Research Institute. We focus on improving child health, transforming pediatric medicine and ensuring healthier futures.
Stanley Manne Children's Research Institute has moved onto the campus of its medical partners creating the promise of greater impact for pediatric research
⚠ COVID-19 INFORMATION
The Heart Center has developed specialized programs to treat certain conditions in the most comprehensive way possible. Browse our list of programs to learn more about the expert-led initiatives that can help treat your child.
Lurie Children’s Pulmonary Hypertension Service cares for children of all ages with pulmonary hypertension, a disease of the very small blood vessels within the lungs, with expertise from Pulmonary Medicine, the Heart Center and Neonatology.
Lurie Children’s Single Ventricle Center of Excellence offers comprehensive treatment for infants, children and adults born with a single functional ventricle pumping blood to the entire body.
Lurie Children’s Turner Syndrome Program includes specialists in endocrinology, cardiology, otolaryngology, audiology, genetics, kidney diseases, neuropsychiatry, nutrition, reproductive endocrinology and ophthalmology.
Lurie Children’s surgeons have advanced methods used to correct vascular rings, were the first in the world to repair a pulmonary artery sling and operate on more pulmonary artery slings than any other hospital in North America.
Lurie Children's Heart Center uses VADs to support the hearts of patients from infancy to young adulthood, including patients with end-stage cardiomyopathy and our most complex congenital heart disease populations. Learn more.
3 of 3 pages